Anxious distress predicts subsequent treatment outcome and side effects in depressed patients starting antidepressant treatment

Journal of Psychiatric Research

Volumn 84, Issue , 2017, Pages 41-48

  Gaspersz, Roxanne ^a   Lamers, Femke ^a   Kent, Justine M ^b   Beekman, Aartjan T F ^a   Smit, Johannes H ^a   van Hemert, Albert M ^c   Schoevers, Robert A ^d   Penninx, Brenda W J H ^a,c,d  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Anxiety disorders; Anxious distress; DSM 5 anxious distress specifier; Epidemiology; Major depressive disorder; Treatment response

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; AGORAPHOBIA; ANTIDEPRESSANT SIDE EFFECT CHECKLIST; ANXIETY ASSESSMENT; ANXIETY DISORDER; ARTICLE; BODY WEIGHT DISORDER; COMORBIDITY; CONSTIPATION; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DEPRESSION ASSESSMENT; DIARRHEA; DISEASE SEVERITY; DISTRESS SYNDROME; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DSM 5 ANXIOUS DISTRESS SPECIFIER; DSM-IV; FEMALE; FOLLOW UP; GENERALIZED ANXIETY DISORDER; HUMAN; HYPERHIDROSIS; INSOMNIA; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL PATIENT; MUSCLE SPASM; NAUSEA; OUTCOME ASSESSMENT; PANIC; PREDICTIVE VALIDITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROGNOSTIC ASSESSMENT; PSYCHOPHARMACOTHERAPY; QUICK INVENTORY OF DEPRESSIVE SYMPTOMS; REMISSION; RESTLESSNESS; SELF REPORT; SEXUAL DYSFUNCTION; SIDE EFFECT ASSESSMENT; SOCIAL PHOBIA; TIC; TREATMENT OUTCOME; TREATMENT RESPONSE; XEROSTOMIA; ADOLESCENT; ANXIETY; COMPLICATION; DEPRESSIVE DISORDER, MAJOR; LONGITUDINAL STUDY; MENTAL STRESS; MIDDLE AGED; NETHERLANDS; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; ANXIETY; DEPRESSIVE DISORDER, MAJOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NETHERLANDS; PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; SELF REPORT; SEVERITY OF ILLNESS INDEX; STRESS, PSYCHOLOGICAL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84988966540     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2016.09.018     Document Type: Article

References (38)

1. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders. fifth ed., 2013, American Psychiatric Association, Arlington, VA.
2. Baek, J.H., Heo, J.Y., Fava, M., Mischoulon, D., Nierenberg, A., Hong, J.P., Roh, S., Jeon, H.J., Anxiety symptoms are linked to new-onset suicidal ideation after six months of follow-up in outpatients with major depressive disorder. J. Affect. Disord. 187 (2015), 183–187.
3. Beck, A.T., Epstein, N., Brown, G., Steer, R.A., An inventory for measuring clinical anxiety: psychometric properties. J. Consult Clin. Psychol 56 (1988), 893–897.
4. Beck, A.T., Kovacs, M., Weissman, A., Assessment of suicidal intention: the scale for Suicide ideation. J. Consult Clin. Psychol 47 (1979), 343–352.
5. Bet, P.M., Hugtenburg, J.G., Penninx, B.W.J.H., Hoogendijk, W.J.G., Side effects of antidepressants during long-term use in a naturalistic setting. Eur. Neuropsychopharmacol. 23 (2013), 1443–1451.
6. Camacho, A., Is anxious-depression an inflammatory state?. Med. Hypotheses 81 (2013), 577–581.
7. Cameron, O.G., Anxious-depressive comorbidity: effects on HPA axis and CNS noradrenergic functions. Essent. Psychopharmacol. 7 (2006), 24–34.
8. Carragher, N., Adamson, G., Bunting, B., McCann, S., Subtypes of depression in a nationally representative sample. J. Affect. Disord. 113 (2009), 88–99.
9. Courtet, P., Jaussent, I., Lopez-Castroman, J., Gorwood, P., Poor response to antidepressants predicts new suicidal ideas and behavior in depressed outpatients. Eur. Neuropsychopharmacol. 24 (2014), 1650–1658.
10. Davidson, J.R.T., Meoni, P., Haudiquet, V., Cantillon, M., Hackett, D., Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms. Depress. Anxiety 16 (2002), 4–13.
11. Domschke, K., Deckert, J., Arolt, V., Baune, B.T., Anxious versus non-anxious depression: difference in treatment outcome. J. Psychopharmacol. 24 (2010), 621–622.
12. Domschke, K., Lawford, B., Laje, G., Berger, K., Young, R., Morris, P., Deckert, J., Arolt, V., McMahon, F.J., Baune, B.T., Brain-derived neurotrophic factor ( BDNF) gene: no major impact on antidepressant treatment response. Int. J. Neuropsychopharmacol. 13 (2010), 93–101.
13. Fava, M., Rush, A.J., Alpert, J.E., Balasubramani, G.K., Wisniewski, S.R., Carmin, C.N., Biggs, M.M., Zisook, S., Leuchter, A., Howland, R., Warden, D., Trivedi, M.H., Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am. J. Psychiatry 165 (2008), 342–351.
14. Gaspersz, R., Lamers, F., Kent, J.M., Beekman, A.T., Smit, J.H., van Hemert, A.M., Schoevers, R.A., Penninx, B.W., Longitudinal predictive validity of the DSM-5 anxious distress specifier for clinical outcomes in a large cohort of patients with major depressive disorder. J. Clin. Psychiatry, 2016, 10.4088/JCP.15m10221.
15. Goldberg, D., Fawcett, J., The importance of anxiety in both major depression and bipolar disorder. Depress. Anxiety 29 (2012), 471–478.
16. Ionescu, D.F., Niciu, M.J., Mathews, D.C., Richards, E.M., Zarate, C.A.J., Neurobiology of anxious depression: a review. Depress. Anxiety 30 (2013), 374–385.
17. Ionescu, D.F., Niciu, M.J., Richards, E.M., Zarate, C.A.J., Pharmacologic treatment of dimensional anxious depression: a review. Prim. Care Companion. CNS Disord., 16, 2014.
18. Lamers, F., de Jonge, P., Nolen, W.A., Smit, J.H., Zitman, F.G., Beekman, A.T.F., Penninx, B.W.J.H., Identifying depressive subtypes in a large cohort study: results from The Netherlands Study of Depression and Anxiety (NESDA). J. Clin. Psychiatry 71 (2010), 1582–1589.
19. Leonard, B.E., Myint, A., The psychoneuroimmunology of depression. Hum. Psychopharmacol. 24 (2009), 165–175.
20. Lingjaerde, O., Ahlfors, U.G., Bech, P., Dencker, S.J., Elgen, K., The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr. Scand. Suppl. 334 (1987), 1–100.
21. Mathers, C.D., Loncar, D., Projections of global mortality and burden of disease from 2002 to 2030. PLoS.Med., 3, 2006, e442.
22. Meller, W.H., Kathol, R.G., Samuelson, S.D., Gehris, T.L., Carroll, B.T., Pitts, A.F., Clayton, P.J., CRH challenge test in anxious depression. Biol. Psychiatry 37 (1995), 376–382.
23. Murray, C.J., Lopez, A.D., Global mortality, disability, and the contribution of risk factors: global Burden of Disease Study. Lancet 349 (1997), 1436–1442.
24. Nelson, J.C., Anxiety does not predict response to duloxetine in major depression: results of a pooled analysis of individual patient data from 11 placebo-controlled trials. Depress. Anxiety 27 (2010), 12–18.
25. Parker, G., Beyond major depression. Psychol. Med. 35 (2005), 467–474.
26. Penninx, B.W., Beekman, A.T., Smit, J.H., Zitman, F.G., Nolen, W.A., Spinhoven, P., Cuijpers, P., de Jong, P.J., van Marwijk, H.W., Assendelft, W.J., van der Meer, K., Verhaak, P., Wensing, M., de Graaf, R., Hoogendijk, W.J., Ormel, J., van Dyck, R., The Netherlands Study of Depression and Anxiety (NESDA): Rationale, Objectives and Methods. 2008, 121–140.
27. Rush, A.J., Gullion, C.M., Basco, M.R., Jarrett, R.B., Trivedi, M.H., The inventory of depressive Symptomatology (IDS): psychometric properties. Psychol. Med. 26 (1996), 477–486.
28. Rush, A.J., Trivedi, M.H., Ibrahim, H.M., Carmody, T.J., Arnow, B., Klein, D.N., Markowitz, J.C., Ninan, P.T., Kornstein, S., Manber, R., Thase, M.E., Kocsis, J.H., Keller, M.B., The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol. Psychiatry 54 (2003), 573–583.
29. Russell, J.M., Koran, L.M., Rush, J., Hirschfeld, R.M., Harrison, W., Friedman, E.S., Davis, S., Keller, M., Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression. Depress. Anxiety 13 (2001), 18–27.
30. Schoevers, R.A., Van, H.L., Koppelmans, V., Kool, S., Dekker, J.J., Managing the patient with co-morbid depression and an anxiety disorder. Drugs 68 (2008), 1621–1634.
31. Tollefson, G.D., Holman, S.L., Sayler, M.E., Potvin, J.H., Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features. J. Clin. Psychiatry 55 (1994), 50–59.
32. Uher, R., Farmer, A., Henigsberg, N., Rietschel, M., Mors, O., Maier, W., Kozel, D., Hauser, J., Souery, D., Placentino, A., Strohmaier, J., Perroud, N., Zobel, A., Rajewska-Rager, A., Dernovsek, M.Z., Larsen, E.R., Kalember, P., Giovannini, C., Barreto, M., McGuffin, P., Aitchison, K.J., Adverse reactions to antidepressants. Br. J. Psychiatry 195 (2009), 202–210.
33. World Health Organization, Composite International Diagnostic Interview, Core Version 2.1: Interviewer's Manual. 1997, World Health Organization, Sydney, Australia.
34. World Health Organization, World Health Organization Collaborating Centre for Drug Statistics Methodology. 2007, World Health Organization, Oslo, Norway.
35. World Health Organization Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC Classification and DDD Assignment 2013. (Oslo, Norway), 2012.
36. Wu, Z., Chen, J., Yuan, C., Hong, W., Peng, D., Zhang, C., Cao, L., Fang, Y., Difference in remission in a Chinese population with anxious versus nonanxious treatment-resistant depression: a report of OPERATION study. J. Affect. Disord. 150 (2013), 834–839.
37. Zimmerman, M., Chelminski, I., Young, D., Dalrymple, K., Walsh, E., Rosenstein, L., A clinically useful self-report measure of the DSM-5 anxious distress specifier for major depressive disorder. J. Clin. Psychiatry 75 (2014), 601–607.
38. Zisook, S., Trivedi, M.H., Warden, D., Lebowitz, B., Thase, M.E., Stewart, J.W., Moutier, C., Fava, M., Wisniewski, S.R., Luther, J., Rush, A.J., Clinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: an examination of citalopram in the STAR*D study. J. Affect. Disord. 117 (2009), 63–73.